Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe
M
M
First Department of Internal Medicine, Shinshu University School of Medicine, Tokyo, Japan.
Suzuki
J
J
Yagita
H
H
Okumura
K
K
Sekiguchi
M
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000917:Antibody Formation; D015815:Cell Adhesion Molecules / Q000276:immunology*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D016029:Receptors, Very Late Antigen / Q000276:immunology*; D016038:Skin Transplantation / Q000276:immunology*; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous; D019010:Vascular Cell Adhesion Molecule-1; D005719:gamma-Globulins / Q000276:immunology / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules; D007166:Immunosuppressive Agents; D016029:Receptors, Very Late Antigen; D019010:Vascular Cell Adhesion Molecule-1; D005719:gamma-Globulins